EM Preview for the week of March 14, 2021

Here's a look at the main drivers in Emerging Markets this week.

Rising US yields remain the biggest risk to EM FX.  As yields fell last week after US CPI data, the dollar softened and EM FX got some traction.  Yields then recovered to end the week at new highs, giving the dollar a boost and putting downward pressure on EM FX.  What’s next?  US retail sales Tuesday and, more importantly, the FOMC decision Wednesday will set the tone for the US rates outlook as we move towards Q2.  We will be sending out an FOMC preview Monday and expect the Fed to push back a little more against a steeper US yield curve, which would be positive for EM FX.

 

AMERICAS

Colombia reports January manufacturing production and retail sales Monday.  Production is expected to fall -1.9% y/y vs. +1.5% in December, while sales are expected to fall -6.7% y/y vs. -2.8% in December.  The economy remains disappointingly weak despite high oil prices.  CPI rose 1.56% y/y in February, near the cycle low of 1.49% from November and well below the 2-4% target range.  Markets see steady rates for much of 2021, with tightening priced in for Q4 and beyond.  We are not convinced and see some room for further easing.  Next policy meeting is March 26.

Brazil COPOM meets Wednesday and is expected to hike rates 50 bp to 2.5%.  Some analysts look for a smaller 25 bp hike, while the CDI market is pricing in 75 bp.  IPCA inflation came in at 5.20% y/y in February, higher than expected and the highest since January 2017.  It is also approaching the top of the 2.25-5.25% target range and may require a stronger response from the central bank.  We suspect the exchange rate may be the deciding factor between a 50 or 75 bp move.  


EUROPE/MIDDLE EAST/AFRICA

Poland reports February CPI Monday.  Headline is expected at 2.6% y/y vs. 2.7% in January.  February core CPI and January trade and current account data will be reported Tuesday.  PPI and industrial output will be reported Thursday.  Real retail sales and construction output will be reported Friday.  Last week, the central bank the latest to become concerned about rising yields and said it may modify its open market operations.  No other details were given but perhaps they will be unveiled at the next policy meeting April 7.  The Polish curve has steepened 35-40 bp over the past month and the pushback supports our view that rate hikes are off the table for the foreseeable future. 

Israel reports February CPI Monday.  Headline is expected at -0.1% y/y vs. -0.4% in January.  If so, it would be the “highest” since March 2020 but still well below the 1-3% target range.  At the last meeting February 22, the central bank left rates steady at 0.10% but said it was more optimistic about 2021 growth even though the risks remain high.  It also noted that shekel weakness since mid-January was supportive for exports and inflation.  FX intervention to weaken the currency remains the primary policy lever, as evidenced by its burgeoning foreign reserves.  Next policy meeting is April 19.

Russia reports February IP Tuesday.  It is expected to fall -2.1% y/y vs. -2.5% in January.  PPI will be reported Wednesday and is expected to rise 8.9% y/y vs. 6.7% in January.  The central bank meets Friday and is expected to keep rates steady at 4.25%. Real retail sales will be reported after the decision and are expected to fall -1.3% y/y vs. -0.1% in January.  CPI rose 5.7% y/y in February, the highest since November 2016 and further above the 4% target.  PPI trends suggest pipeline price pressures are still rising and so markets should be prepared for a tightening cycle to begin sometime this year.

South Africa reports January retail sales Wednesday. Sales are expected to fall -2.2% y/y vs. -1.3% in December.  The economy remains weak while unemployment stands at a record 32.5%.  Meanwhile, CPI rose3.2% y/y in January and remains near the bottom of the 3-6% target range. As such, we simply cannot believe the central bank’s model showing two rate hikes this year.  Next SARB policy meeting is March 25.  While it may be too soon to get a dovish surprise, perhaps the bank can start preparing markets for a possible cut.

Turkey central bank meets Thursday and is expected to hike rates 100 bp to 18.0%.  Unlike previous decisions with a wide disparity of views, analysts are universally looking for 100 bp (though one sees steady rates).  CPI rose 15.61% y/y in February, higher than expected and the highest since July 2019.  With real rates falling since the last hike in December, the bank should deliver a larger than expected hike to reinforce market confidence and so we see slight chances for a hawkish surprise.

ASIA

China reports January and February IP and retail sales Monday.  January and February were combined to avoid y/y distortions from the timing of the Lunar New Year.  However, IP is still expected to surge 32.2% y/y and sales are expected to jump 32.0% y/y.  Low base effects from the pandemic are still quite flattering but there’s no denying that the recovery remains strong. The 2021 growth target of “above 6%” will easily be met but gives policymakers leeway to pare back on its credit-driven recovery.  PBOC sets its 1-year MLF rate sometime this week and is likely to keep it steady at 2.95%.

Indonesia reports February trade data Monday.  Exports are expected to rise 7.87% y/y vs. 12.24%  in January, while imports  are expected to rise 12.05% y/y vs. -6.49%  in January.  Bank Indonesia meets Thursday and is expected to keep rates steady at 3.5%.  CPI rose 1.38% y/y in February, near the cycle low of 1.32% from August and well below the 2.5-4.5% target range.  With the still struggling, we think another rate cut is possible this year but much will depend in the external backdrop and the rupiah.

Singapore reports February trade Wednesday.  NODX are expected to rise 6.3% y/y vs. 12.8% in January.  The recovery continues and so we expect the MAS to keep policy steady at its semiannual meeting in April.  If further stimulus is needed, we expect it will come from the fiscal side.  CPI rose 0.2% y/y in January, the highest since February 2020.  While the MAS does not have an explicit inflation target, low price pressures should allow it to keep policy at its current accommodative settings through 2021.

Taiwan central bank meets Thursday and is expected to keep rates steady at 1.125%.  CPI rose 1.37% y/y in February, the highest since January 2020 but distorted somewhat by the timing of the Lunar New Year holiday.  While the central bank does not have an explicit inflation target, relatively low price pressures should allow it to keep policy steady through 2021.  The strong TWD is helping to dampen inflation but the central bank continues to intervene to slow the appreciation.  Taiwan’s exports remain robust, which Governor Yang said was due to strong demand for semiconductors rather than any perceived unfair advantage from its currency intervention.

More from Mind on the Markets

Brown Brothers Harriman & Co. (“BBH”) may be used as a generic term to reference the company as a whole and/or its various subsidiaries generally. This material and any products or services may be issued or provided in multiple jurisdictions by duly authorized and regulated subsidiaries.This material is for general information and reference purposes only and does not constitute legal, tax or investment advice and is not intended as an offer to sell, or a solicitation to buy securities, services or investment products. Any reference to tax matters is not intended to be used, and may not be used, for purposes of avoiding penalties under the U.S. Internal Revenue Code, or other applicable tax regimes, or for promotion, marketing or recommendation to third parties. All information has been obtained from sources believed to be reliable, but accuracy is not guaranteed, and reliance should not be placed on the information presented. This material may not be reproduced, copied or transmitted, or any of the content disclosed to third parties, without the permission of BBH. All trademarks and service marks included are the property of BBH or their respective owners.© Brown Brothers Harriman & Co. 2021. All rights reserved..

This browser is not fully supported by our public website and may not display or function as expected for this reason. Please note, the Infuse Portal and BBH client applications fully support the IE 11 browser.

Important Information for Non-U.S. Residents

You are required to read the following important information, which, in conjunction with the Terms and Conditions, governs your use of this website. Your use of this website and its contents constitute your acceptance of this information and those Terms and Conditions. If you do not agree with this information and the Terms and Conditions, you should immediately cease use of this website. The contents of this website have not been prepared for the benefit of investors outside of the United States. This website is not intended as a solicitation of the purchase or sale of any security or other financial instrument or any investment management services for any investor who resides in a jurisdiction other than the United States1. As a general matter, Brown Brothers Harriman & Co. and its subsidiaries (“BBH”) is not licensed or registered to solicit prospective investors and offer investment advisory services in jurisdictions outside of the United States. The information on this website is not intended to be distributed to, directed at or used by any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation. Persons in respect of whom such prohibitions apply must not access the website.  Under certain circumstances, BBH may provide services to investors located outside of the United States in accordance with applicable law. The conditions under which such services may be provided will be analyzed on a case-by-case basis by BBH. BBH will only accept investors from such jurisdictions or countries where it has made a determination that such an arrangement or relationship is permissible under the laws of that jurisdiction or country. The existence of this website is not intended to be a substitute for the type of analysis described above and is not intended as a solicitation of or recommendation to any prospective investor, including those located outside of the United States. Certain BBH products or services may not be available in certain jurisdictions. By choosing to access this website from any location other than the United States, you accept full responsibility for compliance with all local laws. The website contains content that has been obtained from sources that BBH believes to be reliable as of the date presented; however, BBH cannot guarantee the accuracy of such content, assure its completeness, or warrant that such information will not be changed. The content contained herein is current as of the date of issuance and is subject to change without notice. The website’s content does not constitute investment advice and should not be used as the basis for any investment decision. There is no guarantee that any investment objectives, expectations, targets described in this website or the  performance or profitability of any investment will be achieved. You understand that investing in securities and other financial instruments involves risks that may affect the value of the securities and may result in losses, including the potential loss of the principal invested, and you assume and are able to bear all such risks.  In no event shall BBH or any other affiliated party be liable for any direct, incidental, special, consequential, indirect, lost profits, loss of business or data, or punitive damages arising out of your use of this website. By clicking accept, you confirm that you accept  to the above Important Information along with Terms and Conditions.

 
1BBH sponsors UCITS Funds registered in Luxembourg, in certain jurisdictions. For information on those funds, please see bbhluxembourgfunds.com


captcha image

Type in the word seen on the picture

I am a current investor in another jurisdiction